Compare

Compare archived captures

This view highlights text differences between two archived captures. It does not interpret meaning or provide guidance.

Descriptive changes only

This comparison highlights text changes between archived captures. It does not interpret the change or provide medical advice. For up-to-date recommendations, always consult the official source website.

Need to cite this comparison? See /cite.

Compare to the live pageView snapshot

Earlier capture

Guidance Documents – Legislation and guidelines – Veterinary drugs - Canada.ca

Apr 18, 2025

legacy-hc-2025-04-21

ID 171105

Original URL ↗
View snapshot

Later capture

Guidance Documents – Legislation and guidelines – Veterinary drugs - Canada.ca

Jan 2, 2026

hc-20260101

ID 429087

Original URL ↗
View snapshot
updated2 sections changed
2 sections changed0 added0 removed+0 / -2 linesChange ratio: 1%
---
+++
@@ -80,7 +80,6 @@
[2012-12-24]
Guidance Document: Data Protection under C.08.004.1 of the Food and Drug Regulations
French-English Lexicon for Standard Labelling Statements
-Guidance Document: Reconsideration of Decisions Issued for Veterinary Drug Submissions
Guidance Document: Fees for the Review of Veterinary Drug Submissions and Applications (formerly Guidance Document on Cost Recovery - Veterinary Drug Submission Evaluation Fees)
Guidance for Industry - Preparation of Veterinary New Drug submissions
Guidance for Industry - Preparation of Veterinary Abbreviated New Drug Submissions - Generic Drugs
@@ -90,5 +89,4 @@
Annex 4 to the Current Edition of the Good Manufacturing Practices Guidelines - Veterinary Drugs (GUI-0012)
Notice: Guidance Document Updates to Reflect New Fees and Policies for April 1, 2020
Page details
-Date modified:
2025-03-18